Hepatitis C Antibody Prevalence in Saudi Arabian Blood Donors

Bernvil, S.S.; Andrews, V.J.; Kariem, A.A.

doi:10.1159/000461372

Cited by 2 publications

(2 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The prevalence of HCV antibodies in blood donors varies in different parts of the world: Germany, 0.24 to 0.79% (7); England, 0.5 to 1% (8); Italy, 0.87% (9); Spain; 1.2% (10); Japan 1.12% (11); and South Africa, 0.6 to 1.2% (12). In the Kingdom of Saudi Arabia, the prevalence of hepatitis C antibody among blood donors from the central part of Saudi Arabia is 1.00 to 1.24% (13,14). A prevalence of 1.7% has recently been reported in the Jeddah area among Saudi blood donors (13).…”

mentioning

confidence: 99%

“…In the Kingdom of Saudi Arabia, the prevalence of hepatitis C antibody among blood donors from the central part of Saudi Arabia is 1.00 to 1.24% (13,14). A prevalence of 1.7% has recently been reported in the Jeddah area among Saudi blood donors (13). The aim of this study was to determine the prevalence of HCV anti-body in the southern part of Saudi Arabia, an area with the highest carrier rate of hepatitis B virus (HBV) (10%) and whether the prevalence of HCV antibodies was influenced by the higher prevalence of HBV infection.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Prevalence of Antibody to Hepatitis C Virus in Saudi Blood Donors

Al-Knawy¹,

El-Mekki

Hamdi

et al. 1995

Canadian Journal of Gastroenterology and Hepatology

View full text Add to dashboard Cite

The prevalence of antibodies to hepatitis C virus (anti-HCV) was retrospectively determined using a second generation enzyme immunoassay in 3868 blood donors from the southern part of Saudi Arabia in an area with high prevalence of hepatitis B virus (HBV) infection. Of 3354 Saudis, 48 (1.43%) were seropositive for anti-HCV. A high prevalence (43 of 204, 21.08%) of anti-HCV was observed among Egyptian donors compared with Saudis (1.43%) and other nationalities (eight of 310, 2.58%). Furthermore, the prevalence of anti-HCV antibodies was observed to increase with age, peaking in the 25 to 34 year age group. From this and other studies conducted in different regions of Saudi Arabia, the prevalence of anti-HCV among Egyptian donors appears to range from 19.2 to 24.5%, and among Saudi donors appears to range from 1.00 to 1.7%, a rate similar to that reported from western countries; this latter rate does not seem to be influenced by the high prevalence of HBV infection in this region.

show abstract